Discussing Low-Dose Naltrexone with Sajad Zalzala

Lifespan.io
20 April 2022
https://www.lifespan.io/news/discussing-low-dose-naltrexone-with-sajad-zalzala/

This drug, known for curbing addictions, has shown other benefits in some patients. Dr. Zalzala responds to questions on the use of low dose naltrexone (LDN).

Research roundup: Recent grants and publications for Emory faculty and staff
Emory News Center
12 April 2022https://news.emory.edu/stories/2022/04/er_research_roundup_april_14-04-2022/story.html

Among others, a grant is: Low dose naltrexone to be studied for chronic neuropathic pain